Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers-Reference-Cited by-同舟云学术

Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

Published:2015-12-30 Issue:12 Volume:10 Page:e0145754
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Pereira Elena,Camacho-Vanegas Olga,Anand Sanya,Sebra Robert,Catalina Camacho Sandra,Garnar-Wortzel Leopold,Nair Navya,Moshier Erin,Wooten Melissa,Uzilov Andrew,Chen Rong,Prasad-Hayes Monica,Zakashansky Konstantin,Beddoe Ann Marie,Schadt Eric,Dottino Peter,Martignetti John A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Cancer Facts & Figs 2015,2015

2. Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial;SS Buys;JAMA,2011

3. Role of tumour markers in monitoring epithelial ovarian cancer;T Meyer;Br J Cancer,2000

4. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography;FR Ueland;Gynecol Oncol,2003

5. Which imaging technique should we use in the follow up of gynaecological cancer?;AC Testa;Best Pract Res Clin Obstet Gynaecol,2014

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas;Journal of Gynecologic Oncology;2025

2. The Role of Circulating Tumor DNA in Ovarian Cancer;Cancers;2024-09-10

3. Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities;Exploration of Targeted Anti-tumor Therapy;2024-06-19

4. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients;Journal of Experimental & Clinical Cancer Research;2024-05-15

5. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis;International Journal of Gynecologic Cancer;2024-04-23